HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Children's Hospital Oakland to celebrate 100th birthday

Children's Hospital & Research Center Oakland is celebrating its 100th birthday. The free-standing, not-for-profit pediatric medical center was founded in 1912 and opened for business in 1914. Children's Hospital Oakland will celebrate the landmark birthday for two years and kicked off festivities with a birthday party at Children's Fairyland in Oakland on September 8.

12 Sep 2012

VOA news examines AIDS among marginalized groups in Burma

VOA News examines AIDS among high-risk groups in Burma, also known as Myanmar. "Burma's AIDS epidemic mostly affects marginalized groups, such as the gay community," the news service writes, adding, "About one percent of Burma's population is HIV-positive," but "among high-risk groups, such as men who have sex with men, health workers estimate as many as 11 percent have HIV."

12 Sep 2012

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

"A paper published in Nature on Monday sheds light on how a vaccine can turn the immune system against [HIV] and so offer protection from infection," Nature News reports, noting "[t]he results are also being presented at the AIDS Vaccine 2012 conference in Boston, Massachusetts, this week."

12 Sep 2012

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

The Economist reports on a demonstration by about 300 people living with HIV and activists outside the headquarters of China's Henan provincial government in Zhengzhou on August 27.

12 Sep 2012

Novel method could help advance fight against persistent 'HIV latency'

Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection-by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.

12 Sep 2012

Religious groups play positive and critical roles in fighting AIDS epidemic

While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive -- and critical -- roles in fighting the epidemic, according to sociologists.

12 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Although people often say they have "strep" throat, most sore throats actually are caused by a virus, not streptococcus bacteria, and shouldn't be treated with antibiotics, suggest guidelines published by the Infectious Diseases Society of America (IDSA). Antibiotics are ineffective against viruses.

11 Sep 2012

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

The Center for Strategic and International Studies (CSIS) on Thursday hosted a panel discussion focusing on the policy implications of findings published by the Lancet in a special series on HIV/AIDS and men who have sex with men (MSM), the Center for Global Health Policy's "Science Speaks" blog reports.

11 Sep 2012

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

Sangamo BioSciences, Inc. announced that data from its Phase 1 clinical programs to develop SB-728-T, a novel therapeutic approach designed to generate a "functional cure" for HIV/AIDS, were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

11 Sep 2012

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.

10 Sep 2012

Study measures cost-effectiveness of on-site rapid HIV testing in drug abuse treatment programs

Less than half of community-based substance abuse treatment programs in the United States currently make HIV testing available on-site or through referral. A new study led by researchers at Weill Cornell Medical College shows the cost-effectiveness of integrating on-site rapid HIV testing into drug treatment programs.

10 Sep 2012

New strategy will have positive impact on people with brain disorders

New research offers a possible strategy for treating central nervous system diseases, such as brain and spinal cord injury, brain cancer, epilepsy, and neurological complications of HIV. The experimental treatment method allows small therapeutic agents to safely cross the blood-brain barrier in laboratory rats by turning off P-glycoprotein, one of the main gatekeepers preventing medicinal drugs from reaching their intended targets in the brain.

10 Sep 2012

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

"With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers of AIDS Vaccine 2012 say," the Center for Global Health Policy's "Science Speaks" blog reports.

7 Sep 2012

NPR blog examines 'test and treat' approach as HIV/AIDS prevention tactic

NPR's "Shots" blog examines the "test and treat" approach to HIV care and prevention, which "relies on the fact that taking HIV drugs dramatically reduces a person's risk of transmitting the virus to others," and, "[a]s more and more people are put on medication, the epidemic theoretically should fizzle out." The blog continues, "Test and treat sounds good on paper, but some doctors and policymakers have doubts about its feasibility on a large scale."

7 Sep 2012

Pesticide-related illnesses to cost up to $90B between 2005-2020 in sub-Saharan Africa, UNEP report says

"The potential cost of pesticide-related illnesses in sub-Saharan African between 2005 and 2020 could reach $90 billion, according to a U.N. report released on Wednesday highlighting the growing health and environmental hazards from chemicals," the Associated Press/Guardian reports.

7 Sep 2012

Reuters examines challenges to implementing 'treatment as prevention,' other HIV prevention strategies in current economic climate

In an "Insight" feature article, Reuters examines how new information on the prevention benefits of HIV treatment and other strategies, such as male circumcision, "could finally break the back of the AIDS epidemic."

7 Sep 2012

Outbreak of autoimmune disease with AIDS-like symptoms in Southeast Asia

There has been an outbreak of an adult-onset immunodeficiency syndrome in Southeast Asia. The autoimmune disease causes AIDS-like symptoms but is not associated with HIV and is not contagious.

7 Sep 2012

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

Mylan Inc. today announced that it and its subsidiary, Mylan Pharmaceuticals Inc., have entered into a settlement agreement with Pfizer Inc., Pharmacia & Upjohn Company LLC and Pfizer Health AB that will resolve the parties' patent litigation in connection with Mylan Pharmaceuticals' Abbreviated New Drug Application (ANDA) for Tolterodine Tartrate ER capsules, 2 mg and 4 mg, which is the generic version of Pfizer's Detrol LA, indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

7 Sep 2012

University of Rhode Island engineers develop new blood-testing technology

A team of engineers and students at the University of Rhode Island has developed an advanced blood-testing technology that incorporates a smartphone application, a hand-held biosensor and a credit card-sized cartridge to provide rapid, accurate biological analysis and wireless communication of test results.

7 Sep 2012

HIV/AIDS News and Research

Further Reading

Children's Hospital Oakland to celebrate 100th birthday

VOA news examines AIDS among marginalized groups in Burma

Researchers present new results from RV144 HIV vaccine trial at AIDS Vaccine 2012

AIDS activists in China protest for better care for those affected by 1990s blood-selling schemes

Novel method could help advance fight against persistent 'HIV latency'

Religious groups play positive and critical roles in fighting AIDS epidemic

First demonstration of newly developed dual humanized FRGTM KO system against malaria

Strep throat should be treated with penicillin or amoxicillin: IDSA guidelines

Speakers at panel discussion explore policy implications of findings on HIV transmission among MSM

Data from Sangamo BioSciences’ SB-728-T Phase 1 clinical programs on HIV/AIDS

HIV viruses with two genetic 'footprints' associated with greater vaccine efficacy

Study measures cost-effectiveness of on-site rapid HIV testing in drug abuse treatment programs

New strategy will have positive impact on people with brain disorders

Researchers, policymakers to gather at AIDS Vaccine 2012 conference in Boston

NPR blog examines 'test and treat' approach as HIV/AIDS prevention tactic

Pesticide-related illnesses to cost up to $90B between 2005-2020 in sub-Saharan Africa, UNEP report says

Reuters examines challenges to implementing 'treatment as prevention,' other HIV prevention strategies in current economic climate

Outbreak of autoimmune disease with AIDS-like symptoms in Southeast Asia

Pfizer, Mylan enter settlement agreement to resolve generic Detrol LA litigation

University of Rhode Island engineers develop new blood-testing technology

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News